Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma
Conditions
- Prolymphocytic Leukemia
- Recurrent Adult Hodgkin Lymphoma
- Recurrent Childhood Hodgkin Lymphoma
- Recurrent Childhood Non-Hodgkin Lymphoma
- Recurrent Chronic Lymphocytic Leukemia
- Recurrent Non-Hodgkin Lymphoma
- Recurrent Small Lymphocytic Lymphoma
- Refractory Childhood Hodgkin Lymphoma
- Refractory Chronic Lymphocytic Leukemia
- Refractory Hodgkin Lymphoma
- Refractory Non-Hodgkin Lymphoma
- Refractory Small Lymphocytic Lymphoma
- T-Cell Chronic Lymphocytic Leukemia
- T-Cell Prolymphocytic Leukemia
Interventions
- PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation
- PROCEDURE: Autologous-Allogeneic Tandem Hematopoietic Stem Cell Transplantation
- DRUG: Carmustine
- DRUG: Cyclophosphamide
- DRUG: Cyclosporine
- DRUG: Cytarabine
- DRUG: Etoposide
- DRUG: Fludarabine Phosphate
- OTHER: Laboratory Biomarker Analysis
- DRUG: Melphalan
- DRUG: Mycophenolate Mofetil
- PROCEDURE: Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation
- PROCEDURE: Peripheral Blood Stem Cell Transplantation
- BIOLOGICAL: Therapeutic Autologous Lymphocytes
- RADIATION: Total-Body Irradiation
Sponsor
Fred Hutchinson Cancer Center
Collaborators